Company Filing History:
Years Active: 1998
Title: M Marchand: Innovator in Lung Cancer Detection
Introduction
M Marchand is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, particularly in the detection of lung adenocarcinomas. His innovative methods have the potential to improve diagnostic accuracy and patient outcomes.
Latest Patents
M Marchand holds a patent for a method that determines lung adenocarcinomas by assaying for the expression of genes coding for tumor rejection antigen precursors MAGE-1, 2, and 3, or their expression products. This patent represents a crucial advancement in the early detection of lung cancer, which is vital for effective treatment.
Career Highlights
M Marchand is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to work on groundbreaking research in oncology. His dedication to improving cancer diagnostics has positioned him as a key figure in the field.
Collaborations
M Marchand collaborates with esteemed colleagues such as Thierry R Boon-Falleur and P Weynants. These partnerships enhance the research efforts and contribute to the development of innovative cancer detection methods.
Conclusion
M Marchand's work in the field of lung cancer detection exemplifies the impact of innovative research on healthcare. His contributions are paving the way for advancements in cancer diagnostics and treatment.